Community/Retail

As the year comes to an end, pharmacy students may be looking forward to a much needed semester break.

It’s that time of the year again where we all feed our faces and start to dread stepping back on the scale. You want to lose the weight but you just can’t stop eating. You keep telling yourself you will start your diet Monday or after the holidays. Not only is all of the food you’re ingesting adding numbers to the scale, but it’s also putting you at an increased risk of developing diseases such as congestive heart disease, hypertension, stroke, type 2 diabetes, and various cancers. Here is some information that may help you keep the weight off and start shedding some pounds.

Novo Nordisk submitted the supplemental New Drug Application (sNDA) based on the results of the BEGIN Young 1 trial, a multi-national, 26-week, phase 3b, randomized, controlled, clinical trial.

Officials with Mylan have announced the launch of generic EpiPen (epinephrine injection, USP) Auto-Injector at half the cost of its brand name counterpart.

In a letter to the new power structure in Washington, D.C., the National Association of Chain Drug Stores (NACDS), the National Community Pharmacists Association (NCPA), the American Pharmacists Association (APhA), and the National Alliance of State Pharmacy Associations (NASPA) have detailed steps necessary to leverage pharmacy patient care and prevent higher costs that result from untreated conditions.

Officials with Clovis Oncology announced today they have received accelerated FDA approval for Rubraca (rucaparib) to treat advanced ovarian cancers in women.

Approximately 1.2 million individuals live with HIV/AIDS in the United States. This population is at an increased risk of opportunistic infections (OIs), an area where pharmacists have significant potential to make meaningful interventions.

Healthy People 2020, the national health promotion and disease intervention initiative, set the goal influenza vaccination rate in the community at 70%. Despite this goal, reports show that vaccination rates are way under expectations at 44%.

Managing cancer pain is a challenge for patients and providers alike.

This weekly video program provides our readers with an in-depth review of the latest news, product approvals, FDA rulings, and more. Our Week in Review is a can't miss for the busy pharmacy professional.

The Drug Enforcement Administration (DEA) National Drug Threat Assessment (NDTA) report sheds light on the extent that illicit and prescription drugs affect the United States.

Drug information references play an important role in pharmacy practice.

I want to challenge every community pharmacy to consider when they need to increase their patient care services to meet their patient's need.

Often-missed requirements for the community pharmacy manager

Watch a product demonstration of Equashield® Pro.

The Academy of Managed Care Pharmacy (AMCP) is proud to join 16 other national nonprofit health care organizations in raising awareness among the provider community of illegal online pharmacies and counterfeit medications.

2017 is just around the corner and to celebrate, Pharmacy Times thought we’ take a look back at some of our top read stories of the past year.

The FDA has issued a drug safety communication for young children and pregnant women regarding the use of general anesthetic and sedation drugs during surgeries or procedures.

The recommended time to begin antiretroviral therapy (called the ART-start threshold) has changed since ART first arrived in the mid 90s. Now, clinicians are able to prescribe ART more liberally because of its improved adverse event profile and wider array of available drugs.

Walmart and Green Dot have announced the introduction of “Prize Savings,” a prize-linked savings incentive program available to the millions of Walmart MoneyCard-holders.

The Kroger Co. has announced a one-time Voluntary Retirement Offering for certain non-store associates.

Walgreens has launched its first Flu Index for the 2016-17 season, a weekly report that ranks the top markets and states for flu activity in the United States.

A recent New England Journal of Medicine publication addressed the rising costs of naloxone, but failed to address many of the hidden issue that are buried within routine pharmacy practice. Here we unveil some of the less obvious reasons and offer software solutions to help pharmacists safe lives.

Mary Golf, PharmD, discusses the latest in research options for CLL management.

What does President-elect Trump and a Republican-controlled Congress claim is in store for healthcare over the next four years?

Adverse effects of medications can irrefutably steer a patient away from taking their medication.